BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6277381)

  • 1. Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular origin.
    Eriksson B; Oberg B; Wahren B
    Biochim Biophys Acta; 1982 Feb; 696(2):115-23. PubMed ID: 6277381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase.
    Eriksson B; Larsson A; Helgstrand E; Johansson NG; Oberg B
    Biochim Biophys Acta; 1980 Mar; 607(1):53-64. PubMed ID: 6245699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
    Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
    Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of herpes simplex virus resistance to disodium phosphonoacetate.
    Duff RG; Robishaw EE; Mao JC; Overby LR
    Intervirology; 1978; 9(4):193-205. PubMed ID: 201588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisodium phosphonoformate, a new antiviral compound.
    Helgstrand E; Eriksson B; Johansson NG; Lannerö B; Larsson A; Misiorny A; Norén JO; Sjöberg B; Stenberg K; Stening G; Stridh S; Oberg B
    Science; 1978 Sep; 201(4358):819-21. PubMed ID: 210500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates.
    Frank KB; Cheng YC
    Antimicrob Agents Chemother; 1985 Apr; 27(4):445-8. PubMed ID: 2988429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of eucaryotic DNA polymerases by phosphonoacetate and phosphonoformate.
    Sabourin CL; Reno JM; Boezi JA
    Arch Biochem Biophys; 1978 Apr; 187(1):96-101. PubMed ID: 655729
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of the cytomegalovirus genome in the presence of PPi analogs.
    Wahren B; Rudén U; Gadler H; Oberg B; Eriksson B
    J Virol; 1985 Dec; 56(3):996-1001. PubMed ID: 2999452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive properties of DNA polymerases induced by herpes simplex virus type-1 and Epstein-Barr virus.
    Allaudeen HS
    Antiviral Res; 1985 Feb; 5(1):1-12. PubMed ID: 2984987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.
    Hess G; Arnold W; Meyer zum Büschenfelde KH
    J Med Virol; 1980; 5(4):309-16. PubMed ID: 6453206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus DNA polymerase inhibition and kinetics.
    Wahren B; Eriksson B
    Adv Enzyme Regul; 1985; 23():263-74. PubMed ID: 3000144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
    Larsson A; Sundqvist A; Parnerud AM
    Mol Pharmacol; 1986 Jun; 29(6):614-21. PubMed ID: 3012321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.
    Reno JM; Lee LF; Boezi JA
    Antimicrob Agents Chemother; 1978 Feb; 13(2):188-92. PubMed ID: 206200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of activities of DNA polymerase alpha, beta, gamma, and reverse transcriptase of L1210 cells by phosphonoacetic acid.
    Allaudeen HS; Bertino JR
    Biochim Biophys Acta; 1978 Oct; 520(3):490-7. PubMed ID: 82450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion of mutations in the thymidine kinase gene in herpes simplex viruses resistant to phosphonoacetate.
    Campione-Piccardo J; Rawls WE
    Can J Microbiol; 1984 May; 30(5):560-4. PubMed ID: 6331620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.
    Derse D; Bastow KF; Cheng Y
    J Biol Chem; 1982 Sep; 257(17):10251-60. PubMed ID: 6286645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of herpes simplex virus DNA polymerase by purine ribonucleoside monophosphates.
    Frank KB; Cheng YC
    J Biol Chem; 1986 Feb; 261(4):1510-3. PubMed ID: 3003073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate.
    Eriksson B; Oberg B
    Antimicrob Agents Chemother; 1979 Jun; 15(6):758-62. PubMed ID: 475360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.
    Margalith M; Falk H; Panet A
    Mol Cell Biochem; 1982 Mar; 43(2):97-103. PubMed ID: 6178013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyribonucleic acid polymerase of wild-type and phosphonoacetic acid-resistant mutant of herpes simplex virus.
    Fridlender B; Chejanovsky N; Becker Y
    Antimicrob Agents Chemother; 1978 Jan; 13(1):124-7. PubMed ID: 204249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.